2018 | Certara

Certara Publishes New Report Investigating Success Factors for Outcomes-based Contracting, Giving Guidelines to Pharma and Payers

2018 年 12 月 19 日

Analytica Laser and BaseCase Introduce Certara Evidence & Access Solutions for US Managed Markets PRINCETON, NJ – Dec. 19, 2018 – Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced a new research report that investigates the potential of pharmaceutical outcomes-based contracting. The paper, entitled “Outcomes-based Agreements … Continued

What’s New in the Simcyp Simulator v18?

2018 年 12 月 5 日

By webdev

Watch this webinar with Nikunjkumar Patel, Shriram Pathak, and Rachel Rose to learn how the latest updates in the Simcyp Simulator v18 will help support developing safer, more effective medications.

Certara Launches BaseCase Toolkits to Facilitate Pharmaceutical and Medical Device Field Teams’ HCP and Payer Presentations

2018 年 12 月 5 日

By webdev

PRINCETON, NJ – Dec. 5, 2018 – Certara today announced the launch of its BaseCase Toolkits, an add-on to BaseCase Interactive which helps pharmaceutical and medical device field representatives better manage and utilize their resources for use during customer presentations.

Certara Launches Trial Simulator 2.3 to Improve Clinical Trial Success

2018 年 11 月 28 日

By webdev

PRINCETON, NJ – Nov. 28, 2018 – Certara today announced the launch of version 2.3 of its Trial Simulator software to help drug developers improve clinical trial design, resulting in greater likelihood of trial success.

Using Realistic Covariates with New Trial Simulator to Optimize Meropenem Dosing in Renally-impaired Children

2018 年 11 月 27 日

By webdev

Learn how to use trial simulation to anticipate risks and preview the range of expected results before millions in R&D dollars are spent, and subjects are exposed to experimental therapies.

Quantifying Age-related Brain Volume Changes to Support Neurodegenerative Disease Drug Development

2018 年 11 月 15 日

By webdev

Watch this webinar to learn why many major pharma organizations are investing in QSP for its potential to improve pharma R&D productivity.

US FDA Awards Certara’s Simcyp Division Two New Dermal Virtual Bioequivalence Grants

2018 年 11 月 14 日

By webdev

PRINCETON, NJ – Nov. 14, 2018 – Certara today announced that it has been awarded two new dermal virtual bioequivalence grants by the US Food and Drug Administration (FDA).

Certara’s Evidence, Value & Access Specialists to Host Symposium on Automation in Public Health Decision-making and Present 18 Posters at ISPOR Europe

2018 年 11 月 8 日

By webdev

PRINCETON, NJ – Nov. 8, 2018 – Certara today announced that its Evidence, Value & Access team will host an educational symposium and present 18 research posters at ISPOR Europe 2018.

Multi-phase Multi-layer Mechanistic Physiologically-based Pharmacokinetic Dermal Absorption Model Verification Including Inter- and Intra-individual Variability Assessment Using Nicotine as a Model Drug

2018 年 11 月 4 日

By webdev

A Comprehensive and Systematic Review of Gastric pH and Factors Affecting Gastric Fluid Volume Dynamics Under Fasted and Fed Conditions in Humans

2018 年 11 月 4 日

By webdev

1 页，共 12 页

Year: 2018